Desheng Weng

専門分野: Clinical oncologist
勤務先: 中国, 広州, Sun Yat-sen University Cancer Center (SYSUCC)
Desheng Wengは、中山大学がんセンターの専門医であり、准教授およびバイオセラピーセンター/悪性黒色腫・肉腫内科の副センター長を務めています。彼の研究は、がん遺伝学（原発性肝細胞癌および胃癌におけるING2、TESTIN、BATF2、LZAP、BIN1などの腫瘍抑制遺伝子の調査）と、包括的な治療アプローチとしてのがん免疫療法にわたります。彼の臨床研究の焦点は、悪性黒色腫と肉腫、および免疫療法に基づくがん治療です。
Desheng Wengは、中山大学がんセンターの専門医であり、准教授およびバイオセラピーセンター/悪性黒色腫・肉腫内科の副センター長を務めています。がん遺伝学の研究と免疫療法を中心とした腫瘍内科診療を組み合わせています。彼の研究には、ING2、TESTIN、BATF2、LZAP、BIN1などの腫瘍抑制遺伝子の研究と、肝細胞癌および胃癌における臨床的特徴との関連性の調査が含まれます。

医師のサービス

遺伝子検査

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Desheng Weng works as a specialist at Sun Yat-sen University Cancer Center, holding the roles of Associate Professor and Deputy Director in the Biotherapy Center and Melanoma and Sarcoma Medical Oncology. His research program connects cancer genetics with immunotherapy, reflecting a biotherapy-centered approach to treating melanoma and sarcoma. In cancer genetics studies, his work includes tumor suppressor gene down-regulation and evaluating genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 in primary hepatocellular carcinoma and gastric cancer. He also investigates how these tumor suppressors relate to clinicopathological parameters and explores their functional roles through in vitro assays such as proliferation, clone formation, motility, invasion, and apoptosis of tumor cell lines. Alongside genetics, Weng’s profile highlights immunotherapy as an important comprehensive method for cancer patients. For international patients, this means he participates in a program where treatment planning is informed by both tumor biology and immunotherapy concepts.

Education

Education details are not specified in the provided profile materials.

Work experience

Associate Professor and Deputy Director, Biotherapy Center / Melanoma and Sarcoma Medical Oncology, Sun Yat-sen University Cancer Center (current role).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Desheng Weng’s clinical-research focus centers on immunotherapy and biotherapy for melanoma and sarcoma, supported by cancer genetics work.

Cancer immunotherapy as a comprehensive treatment approach.
Cancer genetics research, including tumor suppressor gene expression studies (ING2, TESTIN, BATF2, LZAP, BIN1).
Functional evaluation using in vitro proliferation, clone formation, motility, invasion, and apoptosis assays.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Publication and citation metrics are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

Desheng Weng’s role at Sun Yat-sen University Cancer Center places him within a biotherapy and immunotherapy environment for melanoma and sarcoma. The profile materials do not specify spoken languages.